共 10 条
[1]
Altamura AC,Moro AR,Percudani M.Clinical pharmacokinetics of fluoxetine. Clinical Pharmacokinetics . 1994
[2]
Wong S H Y,Dellafera S S,Fernandes R.Determination of fluoxetine and norfluoxetine by high- performance liquid chromatography. Journal of Chromatography . 1990
[3]
MeinekeI,SchreebK,KreβI,etal.Routinemeasurementoffluoxetineanditsnorfluoxetinebyhigh -performanceliquidchro matographywithultravioletdetectioninpatientsunderconcomitanttreatmentwithtricyclicantidepressants. Therapeutic Drug Monitoring . 1998
[4]
FullerRW,WongDT,RobertsonDW.Fluoxetine ,aselec tiveinhibitorofserotoninuptake. MedResRev . 1991
[5]
Nash J F,Bopp R J,Carmichael R H,et al.Determination of fluoxetine and norfluoxetine in plasma by gas chromatography with electron capture detection. Clinical Chemistry . 1982
[6]
von Moltke L L,Greenblatt D J,Duan S X,et al.Human cytochromes mediating N-demethylation of fluoxetine in vitro. Psychopharmacologia . 1997
[7]
Alvarez J C,Bothua D,Collignon I,et al.Determination of fluoxetine and its metabolite norfluoxetine in serum and brain area using high- performance liquid chromatography with ultraviolet detection. Journal of Chromatography B . 1998
[8]
Thomare P,Wang K,van der Meersch - Mongot V,et al.Sensitive micromethod for column liquid chromatographic determination of fluoxetine and norfluoxetine in human plasma. Journal of Chromatography . 1992
[9]
EapCB,GaillardN,PowellK,etal.Simultaneousdetermina tionofplasmalevelsoffluoxamineandenantiomersoffluoxetineandnorfluoxetinebygaschromatography -massspectrometry. JChromatogrB . 1996
[10]
Liu ZQ,Shu Y,Huang S L,et al.Effect of the CYP2C19 genotype and 2C9 on fluoxetine N- demethylation in human liver microsome. Acta Pharmacological Sinica . 2001